Objectives: Meteorin-like peptide (Metrnl), the newly discovered adipokines involves in glucose and lipid metabolism and energy homeostasis. The aim of the present study was to explore the potential predictors of Metrnl by emphasizing the Irisin, glycemic indices, and lipid profile biomarkers in type 2 diabetic patients.

Methods: This cross-sectional study was carried out on 32 obese types 2 diabetic patients, 31 healthy obese, and 30 healthy normal weight people between August 2020 and March 2021. Serum Metrnl and Irisin, fasting blood glucose (FBS), fasting insulin (FI), fasting insulin (FI), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), HbA and eAG levels were measured in a standard manner. To assay insulin resistance and insulin sensitivity, the homeostatic model assessment insulin resistance (HOMA-IR) and quantitative check index (QUICKI) model were used. Quantile regression analysis with the backward elimination method was used to explore predictors. The significant level was defined as p<0.05.

Results: Between variables entered into the model, only the group item showed to be the main predictor of Metrnl in type 2 diabetic patients. Besides, the serum level of Irisin was lower in diabetic patients, and a significant difference was detected between obese diabetic patients and the normal weight group (p=0.024).

Conclusions: Given the multi-causality of diabetes and also the possible therapeutic role of Metrnl in the management of type 2 diabetic patients' abnormalities, designing future studies are needed to discover other predictors of Metrnl and the related mechanisms of Metrnl in the management of diabetes.

Download full-text PDF

Source
http://dx.doi.org/10.1515/hmbci-2022-0037DOI Listing

Publication Analysis

Top Keywords

meteorin-like peptide
8
peptide metrnl
8
type diabetic
8
diabetic patients
8
fasting insulin
8
lipoprotein cholesterol
8
insulin resistance
8
insulin
5
exploration meteorin-like
4
metrnl
4

Similar Publications

Objective: Type 2 diabetes mellitus (T2DM) is a major cause of atherosclerosis, as well as an independent risk factor of cardiovascular adverse events. We aimed to evaluate the association of serum Meteorin-like protein (Metrnl) level with carotid atherosclerosis as determined by carotid intima-media thickness (CIMT) status in subjects with T2DM.

Methods: This cross-sectional study included 83 T2DM subjects without pre-existing cardiovascular diseases.

View Article and Find Full Text PDF

Background: Meteorin-like (Metrnl) is a newly identified secreted protein that plays important roles in metabolic and inflammation-related diseases. Our study aimed to evaluate serum Metrnl levels and establish their relationship with vascular calcification (VC) in hemodialysis (HD) patients.

Methods: In total, 313 HD patients and 41 healthy individuals, as controls, were included.

View Article and Find Full Text PDF

Adipokines and their potential impacts on susceptibility to myocardial ischemia/reperfusion injury in diabetes.

Lipids Health Dis

November 2024

Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macao, PR, China.

Article Synopsis
  • Coronary artery disease poses a significant public health risk, with myocardial ischemia often requiring immediate treatments like thrombolytic therapy to restore blood flow; however, this can lead to additional damage known as ischemia/reperfusion (I/R) injury.
  • Diabetes increases the heart's susceptibility to I/R injury due to issues with metabolism and heightened inflammatory responses, making the roles of adipokines crucial in this context.
  • The review explores recent findings on various adipokines, some of which offer protective effects against heart damage in conditions like obesity and diabetes, while others may worsen inflammation and damage, underscoring the need for further research in this area.
View Article and Find Full Text PDF

Purpose: Meteorin-like (Metrnl) is a novel adipokine which is highly expressed in adipose tissue and has a beneficial effect on glucose and lipid metabolism. High density lipoprotein cholesterol (HDL-C) is well recognized to be inversely associated with cardiovascular events. However, the relationship between serum Metrnl levels and HDL-C in the type 2 diabetes mellitus (T2DM) remains unclear.

View Article and Find Full Text PDF

Secreted proteins have gained more and more attentions, since they can become therapeutic targets, drugs and biomarkers for prevention, diagnosis and treatment of disease and aging. In 2014, Metrnl (also named Meteorin-like, Cometin, Subfatin, Interleukin-39, Interleukin-41, Meteorin-β, and Metrn-β/Metrnβ), as a novel secreted protein released from a certain tissue, was reported by us and others. During the past decade, the number of articles on Metrnl has continued to increase.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!